Guidance: SARS-CoV-2 lateral flow antigen tests: evaluation of VOC1 and VOC2

Public Health England

February 12
14:46 2021


Working with academic collaborators at the University of Oxford, PHE Porton Down has been evaluating the performance of lateral flow devices (LFDs) since mid-August 2020. Over 80 have been considered to date, approximately 30% of which have progressed to extended evaluation on clinical samples at Phase 3.

Published 12 February 2021

Related Articles

Scroll Back To Top 📄More Articles


Scroll Back To Top Write Comment
  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Scroll Back To Top
Your name:
Your email:

Post my comment

News Calendar

Recent Comments

Follow Us on Twitter

Share This

Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: